8-K: Innovative MedTech Appoints New Auditor, Astra Audit & Advisory LLC, Replacing Accell Audit & Compliance

Sentiment:

Auditor Change Announcement


Innovative MedTech, Inc. has changed its independent auditor from Accell Audit & Compliance, P.A. to Astra Audit & Advisory LLC, effective June 10, 2024.

Summary

  • Innovative MedTech, Inc. has appointed Astra Audit & Advisory LLC as their new independent registered public accounting firm on June 10, 2024.
  • This change resulted in the dismissal of Accell Audit & Compliance, P.A. as their previous auditor.
  • The decision to appoint Astra was approved by the company's Board of Directors.
  • There were no disagreements with Accell on accounting principles, financial statement disclosure, or auditing scope during the two most recent fiscal years and through the date of dismissal.
  • Accell's reports on the company's financial statements for the fiscal years ended June 30, 2023 and 2022 did not contain any adverse opinion or disclaimer of opinion, but did include an explanatory paragraph regarding the company's ability to continue as a going concern and identified certain material weaknesses in internal controls.
  • Innovative MedTech has not previously consulted with Astra on accounting principles or audit opinions prior to their engagement.
  • Accell has confirmed that they agree with the statements made by Innovative MedTech regarding the change in auditors.

Sentiment

Score: 4

Explanation: The change in auditors itself is neutral, but the going concern issue and material weaknesses in internal controls identified by the previous auditor are negative factors.

Positives

  • The transition to a new auditor was completed without any reported disagreements on accounting or auditing matters.
  • Accell has confirmed the accuracy of the statements made by Innovative MedTech regarding the change in auditors.

Negatives

  • Accell's audit reports included an explanatory paragraph about the company's ability to continue as a going concern.
  • Accell's reports identified material weaknesses in the company's internal controls over financial reporting.

Risks

  • The company's ability to continue as a going concern has been questioned by the previous auditor.
  • Material weaknesses in internal controls over financial reporting have been identified by the previous auditor.

Management Comments

  • The appointment of Astra was approved by the Board of Directors of the Company.

Industry Context

Changes in auditors are a common occurrence, but the reasons for the change and any disagreements or concerns raised by the previous auditor are important for investors to consider. The fact that the previous auditor raised concerns about the company's ability to continue as a going concern is a significant issue.

Comparison to Industry Standards

  • The change of auditors is not unusual, but the lack of disagreements is a positive sign.
  • The going concern issue raised by Accell is a concern that needs to be addressed by the company and the new auditor.
  • The material weaknesses in internal controls are also a concern that needs to be addressed.

Stakeholder Impact

  • Shareholders should be aware of the change in auditors and the concerns raised by the previous auditor.
  • Creditors should be aware of the going concern issue.

Next Steps

  • Astra Audit & Advisory LLC will audit the company's financial statements for the fiscal year ending June 30, 2024.

Key Dates

DateDescription
June 10, 2024Astra Audit & Advisory LLC was appointed as the new independent auditor, and Accell Audit & Compliance, P.A. was dismissed.
June 29, 2024Accell provided a letter to the SEC confirming their agreement with the statements made by Innovative MedTech regarding the change in auditors.
July 1, 2024The 8-K report was signed and filed.

Keywords

auditor, accounting, financial statements, Astra Audit & Advisory LLC, Accell Audit & Compliance, internal controls, going concern

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.